AAPL   322.21 (+1.56%)
MSFT   183.97 (+1.19%)
FB   228.57 (-0.25%)
AMZN   2,427.88 (+0.73%)
NVDA   347.11 (+1.79%)
BABA   201.38 (+0.10%)
GE   6.88 (-5.76%)
TSLA   815.88 (-0.53%)
T   31.46 (-1.22%)
DIS   117.53 (-3.29%)
BAC   25.31 (-2.58%)
BA   152.55 (+2.03%)
AAPL   322.21 (+1.56%)
MSFT   183.97 (+1.19%)
FB   228.57 (-0.25%)
AMZN   2,427.88 (+0.73%)
NVDA   347.11 (+1.79%)
BABA   201.38 (+0.10%)
GE   6.88 (-5.76%)
TSLA   815.88 (-0.53%)
T   31.46 (-1.22%)
DIS   117.53 (-3.29%)
BAC   25.31 (-2.58%)
BA   152.55 (+2.03%)
AAPL   322.21 (+1.56%)
MSFT   183.97 (+1.19%)
FB   228.57 (-0.25%)
AMZN   2,427.88 (+0.73%)
NVDA   347.11 (+1.79%)
BABA   201.38 (+0.10%)
GE   6.88 (-5.76%)
TSLA   815.88 (-0.53%)
T   31.46 (-1.22%)
DIS   117.53 (-3.29%)
BAC   25.31 (-2.58%)
BA   152.55 (+2.03%)
AAPL   322.21 (+1.56%)
MSFT   183.97 (+1.19%)
FB   228.57 (-0.25%)
AMZN   2,427.88 (+0.73%)
NVDA   347.11 (+1.79%)
BABA   201.38 (+0.10%)
GE   6.88 (-5.76%)
TSLA   815.88 (-0.53%)
T   31.46 (-1.22%)
DIS   117.53 (-3.29%)
BAC   25.31 (-2.58%)
BA   152.55 (+2.03%)
Log in

NASDAQ:CLSDClearside Biomedical Earnings Date, Estimates & History

$1.95
-0.13 (-6.25 %)
(As of 05/28/2020 03:21 PM ET)
Add
Compare
Today's Range
$1.93
Now: $1.95
$2.09
50-Day Range
$1.57
MA: $1.97
$2.41
52-Week Range
$0.56
Now: $1.95
$4.13
Volume273,609 shs
Average Volume385,909 shs
Market Capitalization$87.50 million
P/E RatioN/A
Dividend YieldN/A
Beta1.12

Earnings

Clearside Biomedical (NASDAQ:CLSD) Earnings Information

Clearside Biomedical last issued its earnings data on May 8th, 2020. The reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.04. The company had revenue of $4.10 million for the quarter, compared to the consensus estimate of $4 million. Clearside Biomedical has generated ($0.81) earnings per share over the last year. Clearside Biomedical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2020 based off prior year's report dates.

Clearside Biomedical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Clearside Biomedical (NASDAQ:CLSD) Earnings Estimates

2020 EPS Consensus Estimate: ($0.51)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.18)($0.18)($0.18)
Q2 20201($0.11)($0.11)($0.11)
Q3 20201($0.11)($0.11)($0.11)
Q4 20201($0.11)($0.11)($0.11)
Q1 20211($0.11)($0.11)($0.11)
Q2 20211($0.11)($0.11)($0.11)

Clearside Biomedical (NASDAQ CLSD) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/5/2020
(Estimated)
       
5/8/20203/31/2020($0.11)($0.07)($0.07)$4.00 million$4.10 millionTranscript
3/11/202012/31/2019($0.07)($0.07)($0.07)$5.90 million$1.94 millionTranscript
11/6/2019Q3($0.16)($0.17)($0.17)$0.05 million$0.14 millionListen
8/7/2019Q2 2019($0.37)($0.15)($0.15)$0.05 million$0.05 millionN/A
5/8/20193/31/2019($0.36)($0.45)($0.45)$0.05 millionN/A
3/12/201912/31/2018($0.55)($0.68)($0.68)$0.03 millionTranscript
11/8/2018Q3($0.63)($0.75)($0.75)N/A
8/8/2018Q2 2018($0.58)($0.65)($0.65)N/A
5/9/2018Q1 2018($0.57)($0.62)($0.62)$0.09 millionN/A
3/14/2018Q4 2017($0.70)($0.65)($0.65)$0.10 million$0.06 millionTranscript
11/8/2017Q3 2017($0.55)($0.72)($0.72)$0.01 million$0.16 millionN/A
8/9/20176/30/2017($0.41)($0.54)($0.54)$0.13 millionListen
5/10/20173/31/2017($0.44)($0.41)($0.41)$0.01 millionN/A
3/14/2017Q4 2016($0.33)($0.45)($0.45)$0.01 million$0.01 millionN/A
11/9/20169/30/2016($0.45)($0.28)($0.28)$0.01 million$0.01 millionListen
8/11/2016Q2($0.32)($0.62)($0.62)$0.01 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.